What does maintenance after Wegovy actually look like?

Why does weight tend to come back after stopping Wegovy?

Semaglutide reduces hunger by activating GLP-1 receptors in the brain and gut. While you take it, appetite signals are quieter, food moves through the stomach a little more slowly, and many people find eating less feels genuinely manageable rather than a feat of self-denial. That changes when the medicine stops. The biology that drove weight gain in the first place (appetite-regulating hormones, metabolic rate, genetic predisposition) reasserts itself, often quite quickly.

A large randomised trial published in the New England Journal of Medicine found that participants who stopped semaglutide after 68 weeks regained most of the weight they had lost within the following year, whereas those who continued maintained their results. This is not a personal failing. It is the pharmacology working as designed, and it is why the conversation about maintenance should start well before you get there, not after.

If you want to understand the full titration pathway before reaching maintenance, the Wegovy doses overview sets out how each stage works.

What does staying on Wegovy at a maintenance dose involve?

For most people on Wegovy injection, the standard maintenance dose is 2.4 mg once weekly. The MHRA approved a higher 7.2 mg dose in January 2026 (initially delivered as three 2.4 mg pens) and then approved a dedicated single-dose 7.2 mg pen in April 2026, designed to be simpler to use. The 7.2 mg option is licensed for adults with a BMI of 30 or above. Trials at this higher dose reported around 20.7% average weight reduction over 72 weeks, which begins to close the gap with tirzepatide results.

At the maintenance stage, the prescriber's job shifts. They are no longer titrating you upward; they are asking whether the current dose is still clinically appropriate, whether side effects are manageable, whether your weight is stable, and whether continuing serves your health. At nume, a clinician reviews the full picture before every repeat, not a tick-box exercise. What happens to your Wegovy dose after reaching goal weight is a question worth reading before that review conversation.

One quick check worth building into a routine: each week before your injection, note your weight on your phone. It takes under a minute and gives your prescriber a real pattern to work with, rather than a single data point at review.

What does the NHS say about long-term Wegovy use?

NICE's appraisal of semaglutide, TA875, recommends it for a maximum of two years for eligible NHS patients within a specialist weight management service that includes multidisciplinary support. The eligibility criteria include a BMI of 35 or above (lower for some ethnic backgrounds) and at least one weight-related health condition. If less than 5% weight loss is achieved after six months at the maintenance dose, NICE recommends reconsidering continuation.

For most people on the NHS, Wegovy is accessed through these specialist services. Waiting lists can be long. NHS England's guidance on weight management injections explains what that pathway involves in practice, including the lifestyle support that must accompany the medicine.

Private treatment operates under the licensed SmPC criteria rather than NICE's NHS commissioning rules. That means there is no two-year cap in private prescribing, but it also means every repeat still requires clinical justification. Duration is a clinical question, not an administrative one. Our guide to building a Wegovy maintenance plan covers how to approach that conversation with a prescriber.

Is stopping Wegovy ever the right plan, and how should it be done?

For some people, the goal is always time-limited treatment, losing weight to a point where lifestyle changes alone can sustain the result. That can work, but it is most likely to succeed when stopping is planned, gradual, and supported. Abrupt cessation after a long period at 2.4 mg is the pattern most associated with rapid weight regain in practice.

A structured stopping plan might involve stepping the dose down slowly over several months, reinforcing eating habits and activity during that period, and having a clear threshold at which to restart if weight regains significantly. The question of whether Wegovy has a formal maintenance dose is worth exploring alongside this, because it shapes how prescribers frame the options.

The side-effect picture also shifts at this stage. Common gastrointestinal symptoms (nausea, constipation, reflux) often ease once a person has been at the same dose for several months. If they have not settled, that is a clinical conversation worth having. For broader context on how the treatment fits into a longer weight-loss journey, the weight-loss treatment overview outlines the landscape. And if you want to understand what private Wegovy costs for ongoing treatment, the Wegovy price page sets out what a transparent private prescription includes.

Maintenance is not the finish line, it is where the sustained clinical support matters most. If you would like a prescriber to review whether Wegovy is still the right approach for you, or whether your dose needs adjusting, check your eligibility with our clinical team.